JM SMUCKER CO/THE (SJM)       136.59  -2.93 (-2.1%)

136.59  -2.93 (-2.1%)

US8326964058 - Common Stock - After market: 136.59 0 (0%)


Fundamental Rating

4

Taking everything into account, SJM scores 4 out of 10 in our fundamental rating. SJM was compared to 101 industry peers in the Food Products industry. SJM has a medium financial health rating, its profitability is only medium as well. SJM is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

SJM has a Return On Assets of 3.61%. This is better than the industry average of 1.35%.
SJM's Profit Margin of 7.33% is amongst the best of the industry. SJM does better than the industry average Profit Margin of 1.90%.

The Piotroski-F score of SJM is 6.00. This is a neutral score and indicates average health and profitability for SJM.
SJM has a Return On Equity of 7.21%. This is below the industry average of 13.46%.
VS Industry

ROA (3.61%) VS Industry: 62% outperformed.

-113.79
17.66

ROE (7.21%) VS Industry: 29% outperformed.

0.27
56.35

Profit Margin (7.33%) VS Industry: 80% outperformed.

-1,579.19
58.94

Valuation

Valuation Rating

3

Compared to an average industry Price/Earning Ratio of 19.65, SJM is valued a bit cheaper than its industry peers.
The Price/Earnings Ratio is 15.77, which indicates a correct valuation of SJM.
The Forward Price/Earnings Ratio of 14.29 indicates a correct valuation of SJM.
When comparing the current price to the book value of SJM, we can conclude it is valued correctly. It is trading at 1.79 times its book value.

When comparing the price book ratio of SJM to the average industry price book ratio of 1.68, SJM is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 13.71, SJM is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry

Price/Earnings (15.77) VS Industry: 68% outperformed.

272.81
0.32

Price/Book (1.79) VS Industry: 46% outperformed.

30.77
0.03

Enterprise Value/ EBITDA (12.25) VS Industry: 59% outperformed.

233.44
0.24

Growth

Growth Rating

5

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
SJM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.35%.
The Earnings Per Share has been growing slightly by 2.89% on average over the past 5 years.

SJM is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.14% yearly.
The Revenue has been growing slightly by 1.58% in the past year.
The Revenue has been growing slightly by 1.59% on average over the past 5 years.
Based on estimates for the next 5 years, SJM will show a small growth in Revenue. The Revenue will grow by 2.08% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.89% 2.36% 0.35% -5.1% 3.7% 3.5% 5.14%
Revenue1.59% 0.68% 1.58% 5.01% 3.78% 2.73% 2.08%

Health

Health Rating

4

A Current Ratio of 1.05 indicates that SJM should not have too much problems paying its short term obligations.
The Debt to Equity ratio of SJM is in line with the industry averages.
SJM has an Altman-Z score of 2.05. This is not the best score and indicates that SJM is in the grey zone with still only limited risk for bankruptcy at the moment.
SJM has a Altman-Z score comparable to the industry average, which is at 2.28.

SJM has a Piotroski-F score of 6.00. This indicates an average health and profitability for SJM.
When comparing the Current Ratio of SJM to the average industry Current Ratio of 1.88, SJM is less able to pay its short term obligations than its industry peers. 83% of its industry peers have a better Current Ratio.
SJM has a Quick Ratio of 1.05. This is a bad value and indicates that SJM is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 0.95, SJM is worse placed to pay its short term obligations than its industry peers. 89% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.53) VS Industry: 46% outperformed.

7.48
0.00

Quick Ratio (0.45) VS Industry: 11% outperformed.

0.10
37.12

Current Ratio (1.05) VS Industry: 17% outperformed.

0.13
37.46

Altman-Z (2.05) VS Industry: 44% outperformed.

-21.70
63.12

Dividend

Dividend Rating

4

SJM has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 2.94%, SJM has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.94, SJM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.48, SJM has a dividend comparable with the average S&P500 company.

The dividend of SJM has a limited annual growth rate of 5.14%.
The dividend of SJM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
SJM pays out 72.50% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (2.94%) VS Industry: 51% outperformed.

0.99
11.03
SJM Daily chart

JM SMUCKER CO/THE136.59

NYSE:SJM (9/27/2022, 3:29:36 PM)-2.93 (-2.1%)

After market: 136.59 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 08-23 2022-08-23/bmo Earnings (Next) 11-21 2022-11-21
Ins Owners 1.29% Inst Owners 81.87%
Market Cap 14.55B Analysts 52.5
Valuation
PE 15.77 Fwd PE 14.29
PEG (NY) N/A PEG (5Y) 5.46
P/S 1.82 P/B 1.79
EV/EBITDA 12.25
Dividend
Dividend Yield 2.94% Dividend Growth 5.14%
DP 72.5% Ex-Date 08-11 2022-08-11 (1.02)
Growth
EPS 1Y 0.35% EPS 3Y 2.36%
EPS 5Y 2.89% EPS growth Q2Q -12.11%
EPS Next Y -5.1% EPS Next 2Y 3.7%
EPS Next 3Y 3.5% EPS Next 5Y 5.14%
Revenue growth 1Y 1.58% Revenue growth 3Y 0.68%
Revenue growth 5Y 1.59% Revenue growth Q2Q 0.81%
Revenue Next Year 5.01% Revenue Next 2Y 3.78%
Revenue Next 3Y 2.73% Revenue Next 5Y 2.08%
Health
Current Ratio 1.05 Quick Ratio 0.45
Altman-Z 2.05 F-Score 6
Debt/Equity 0.53
Profitability
ROA 3.61% ROE 7.21%
ROIC 28.84% ROICg 5.72%
PM 7.33 OM 13.82
Asset Turnover 0.49

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA